Evaluation of dosing and clinical response to darbepoetin alfa (DA) and epoetin alfa (EPO) in patients treated for chemotherapy-induced anemia in hospital oncology outpatient clinics.

被引：0
|
作者：
Gupta, V
Rago, MA
Goetz, A
Fastenau, J
Watson, S
机构：
[1] Cardinal Hlth Clin Serv & Consulting, Pharmaceut & Clin Informat Serv, Houston, TX USA
[2] Ortho Biotech, Clin Affairs, Bridgewater, NJ USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5768
引用
收藏
页码：509B / 509B
页数：1
相关论文
共 50 条
  • [1] Effectiveness of darbepoetin alfa versus epoetin alfa in patients with chemotherapy-induced anemia treated in clinical practice
    Patton, J
    Reeves, T
    Wallace, J
    ONCOLOGIST, 2004, 9 (04): : 451 - 458
  • [2] EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CHEMOTHERAPY-INDUCED ANEMIA INPATIENTS
    Lafeuille, M. H.
    Forlenza, J. B.
    Khan, A.
    Laliberte-Auger, F.
    Lefebvre, P.
    VALUE IN HEALTH, 2012, 15 (04) : A213 - A214
  • [3] Utilization of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia
    Herrington, JD
    Davidson, SL
    Tomita, DK
    Green, L
    Smith, RE
    Boccia, RV
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (01) : 54 - 62
  • [4] Comparison of epoetin alfa (EPO) and darbepoetin alfa (DARB) utilization in cancer chemotherapy patients treated in a hospital outpatient setting
    Vekeman, F.
    LaFeuille, M.
    Bailey, R.
    Piech, C. Tak
    McKenzie, R. S.
    Lefebvre, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Therapeutic interchange of darbepoetin alfa for epoetin alfa for chemotherapy-induced anemia.
    Blamble, DA
    Shermock, KM
    Nesbit, TW
    Pinto, B
    Fetting, J
    PHARMACOTHERAPY, 2004, 24 (10): : 1477 - 1477
  • [6] DARBEPOETIN ALFA VERSUS EPOETIN ALFA FOR TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA: A HEALTH ECONOMIC EVALUATION
    Finek, J.
    Holubec, L.
    Wiesnerova, A.
    Pav, Z.
    Dusek, L.
    TUMOR BIOLOGY, 2010, 31 : S102 - S103
  • [7] DARBEPOETIN ALFA VERSUS EPOETIN ALFA FOR TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA: A HEALTH ECONOMIC EVALUATION
    Finek, J.
    Holubec, L.
    Wiesnerova, A.
    Pav, Z.
    Dusek, V.
    ANNALS OF ONCOLOGY, 2010, 21 : 344 - 344
  • [8] Evaluation of clinical use of darbepoetin alfa in patients with chemotherapy-induced anemia
    Bustos, A.
    Cruz, M. A.
    Aramburo, P.
    Carabantes, F.
    Diaz, N.
    Florian, J.
    Lazaro, M.
    Martin de Segovia, J. M.
    Gasquet, J. A.
    Alegre, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Epoetin Alfa and Darbepoetin Alfa in Clinical Practice in Patients With Chemotherapy Induced Anemia in the Netherlands (EVALUATE)
    van Groeningen, C. J.
    Kok, T. C.
    Biesma, B.
    Melissant, C. F.
    de Klerk, G.
    Brok, R. G. P. M.
    Lahaye, M.
    Milek, R. L. B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S237 - S237
  • [10] COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA OUTPATIENTS
    Lafeuille, M. H.
    Bailey, R. A.
    Senbetta, M.
    McKenzie, R. S.
    Lefebvre, P.
    VALUE IN HEALTH, 2011, 14 (03) : A160 - A160
12345